SCHEMBL7172189

SCHEMBL7172189

CCCCOc1ccc(NC(C(=O)NC(C)C(C)(C)CC(N)=O)C(O)C(=O)NO)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.44
S1PR1 P21453 4/20 0.38
S1PR3 Q99500 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
PDE4A P27815 1/20 0.37
HIF1A Q16665 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
MAPK1 P28482 1/20 0.37
SAE1 Q9UBE0 1/20 0.37
UBA2 Q9UBT2 1/20 0.37
FAAH O00519 1/20 0.36
MMP1 P03956 2/20 0.36
ACACB O00763 1/20 0.36
MMP3 P08254 1/20 0.36
MMP9 P14780 1/20 0.36
PPARA Q07869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7174038 0.84 TAAR1 (0.39) MMP1MMP3MMP9MMP2MMP13
SCHEMBL7172185 0.81 MMP3 (0.55) PPARGMMP1MMP3MMP9ADAMTS4
SCHEMBL7172194 0.80 PPARG (0.41) PPARGS1PR1S1PR3SMN1; SMN2KDM4E
SCHEMBL7172616 0.78 MMP3 (0.46) PPARGSMN1; SMN2KDM4ECYP1A2CYP2D6
SCHEMBL7177123 0.78 MMP3 (0.57) PPARGMMP1MMP3MMP9MMP2
SCHEMBL7174311 0.76 MMP3 (0.48) PPARGS1PR1S1PR3MMP1MMP3
SCHEMBL7172637 0.76 SMN1; SMN2 (0.42) SMN1; SMN2MAPK1MMP1ACACBMMP3
SCHEMBL7177453 0.76 MMP3 (0.55) MMP1MMP3MMP9MMP2
SCHEMBL7170041 0.74 MMP3 (0.52) PPARGSMN1; SMN2MMP1MMP3MMP9
SCHEMBL7170036 0.74 MMP2 (0.57) MMP1MMP3MMP9MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576628-B1 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis ROCHE DIAGNOSTICS GMBH (DE) 2003-06-10 US disclosed